Mathematical model of brain tumour with glia-neuron interactions and chemotherapy treatment.

In recent years, it became clear that a better understanding of the interactions among the main elements involved in the cancer network is necessary for the treatment of cancer and the suppression of cancer growth. In this work we propose a system of coupled differential equations that model brain tumour under treatment by chemotherapy, which considers interactions among the glial cells, the glioma, the neurons, and the chemotherapeutic agents. We study the conditions for the glioma growth to be eliminated, and identify values of the parameters for which the inhibition of the glioma growth is obtained with a minimal loss of healthy cells.

[1]  Nicola Bellomo,et al.  A Survey of Models for Tumor-Immune System Dynamics , 1996 .

[2]  T. Otis,et al.  Glia get excited , 2008, Nature Neuroscience.

[3]  M. Roddie,et al.  Phase I trial of temozolomide using an extended continuous oral schedule. , 1998, Cancer research.

[4]  M. Linskey,et al.  Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy , 2011, Neurology.

[5]  Frank Nani,et al.  A chemotherapy model for the treatment of cancer with metastasis , 2002 .

[6]  P. Glees Neuroglia : morphology and function , 1955 .

[7]  Nicola J. Allen,et al.  Neuroscience: Glia — more than just brain glue , 2009, Nature.

[8]  W. Rzeski,et al.  Anticancer agents are potent neurotoxins in vitro and in vivo , 2004, Annals of neurology.

[9]  W. Schuette Treatment of brain metastases from lung cancer: chemotherapy. , 2004, Lung cancer.

[10]  H. Sontheimer,et al.  Glioma cells release excitotoxic concentrations of glutamate. , 1999, Cancer research.

[11]  T. Wheldon Mathematical models in cancer research , 1988 .

[12]  Xihui Gao,et al.  Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier. , 2014, Small.

[13]  Yongzhen Pei,et al.  Extinction and permanence of one-prey multi-predators of Holling type II function response system with impulsive biological control. , 2005, Journal of theoretical biology.

[14]  Yuri Kogan,et al.  Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics , 2008 .

[15]  T. Fukushima,et al.  Efficacy of temozolomide treatment in patients with high-grade glioma. , 2009, Anticancer research.

[16]  Pier Paolo Delsanto,et al.  Nutrient competition as a determinant for cancer growth , 1999 .

[17]  V. Tiwari,et al.  Modulating the delicate glial–neuronal interactions in neuropathic pain: Promises and potential caveats , 2014, Neuroscience & Biobehavioral Reviews.

[18]  N. Shapiro,et al.  Tumor growth and chemotherapy: Mathematical methods, computer simulations, and experimental foundations , 1973 .

[19]  Johan Pallud,et al.  A Tumor Growth Inhibition Model for Low-Grade Glioma Treated with Chemotherapy or Radiotherapy , 2012, Clinical Cancer Research.

[20]  J. Dichgans,et al.  Chemotherapy‐induced cell death in primary cerebellar granule neurons but not in astrocytes: in vitro paradigm of differential neurotoxicity , 2004, Journal of neurochemistry.

[21]  Feng-Yi Yang,et al.  Pharmacokinetics of BPA in Gliomas with Ultrasound Induced Blood-Brain Barrier Disruption as Measured by Microdialysis , 2014, PloS one.

[22]  N. McGranahan,et al.  The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.

[23]  M. Weller,et al.  New (alternative) temozolomide regimens for the treatment of glioma. , 2009, Neuro-oncology.

[24]  Webster K. Cavenee,et al.  The 2007 WHO ClassiWcation of Tumours of the Central Nervous System , 2007 .

[25]  D. Louis WHO classification of tumours of the central nervous system , 2007 .

[26]  U. Linz Chemotherapy for glioblastoma , 2008, Cancer.

[27]  Ü. Langel,et al.  Peptide-Based Delivery of Oligonucleotides Across Blood–Brain Barrier Model , 2013, International Journal of Peptide Research and Therapeutics.

[28]  S. Shaham Glia-neuron interactions in nervous system function and development. , 2005, Current topics in developmental biology.

[29]  A. Papadimitropoulos,et al.  "In vitro" 3D models of tumor-immune system interaction. , 2014, Advanced drug delivery reviews.

[30]  K. Fujioka,et al.  The effect of PTEN on proliferation and drug-, and radiosensitivity in malignant glioma cells. , 2011, Anticancer research.

[31]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[32]  J. Weille On the Genesis of Neuroblastoma and Glioma , 2014 .

[33]  H. I. Freedman,et al.  A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy , 2013 .

[34]  C. S. Holling,et al.  The functional response of predators to prey density and its role in mimicry and population regulation. , 1965 .

[35]  Isaac Yang,et al.  The role of microglia in central nervous system immunity and glioma immunology , 2010, Journal of Clinical Neuroscience.

[36]  W. Hahn,et al.  Modelling the molecular circuitry of cancer , 2002, Nature Reviews Cancer.

[37]  Harald Sontheimer,et al.  A neurocentric perspective on glioma invasion , 2014, Nature Reviews Neuroscience.

[38]  J. Spratt,et al.  Rates of Growth of Pulmonary Metastases and Host Survival , 1964, Annals of surgery.

[39]  S. Chaudhuri,et al.  Microglial action in glioma: a boon turns bane. , 2010, Immunology letters.

[40]  Ponta Grossa,et al.  Model for tumour growth with treatment by continuous and pulsed chemotherapy , 2014 .

[41]  Philip Gerlee,et al.  The Impact of Phenotypic Switching on Glioblastoma Growth and Invasion , 2012, PLoS Comput. Biol..

[42]  A. Meyer-Franke,et al.  Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture , 1995, Neuron.

[43]  R. Fields Advances in understanding neuron-glia interactions. , 2005, Neuron glia biology.

[44]  H. Friedman,et al.  Temozolomide and treatment of malignant glioma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  D. F. Andrews,et al.  A one-hit model of cell death in inherited neuronal degenerations , 2000, Nature.

[46]  Yuji Ikegaya,et al.  A Statistical Method of Identifying Interactions in Neuron–Glia Systems Based on Functional Multicell Ca2+ Imaging , 2014, PLoS Comput. Biol..

[47]  Frederico A. C. Azevedo,et al.  Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled‐up primate brain , 2009, The Journal of comparative neurology.

[48]  P. Maini,et al.  A cellular automaton model for tumour growth in inhomogeneous environment. , 2003, Journal of theoretical biology.

[49]  Moustapha Hassan,et al.  Cyclophosphamide Pharmacokinetics in Mice: A Comparison Between Retro Orbital Sampling Versus Serial Tail Vein Bleeding , 2008 .

[50]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[51]  A. Cianciulli,et al.  Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[52]  Alexandre G. Ciancio,et al.  Qualitative analysis of second-order models of tumor-immune system competition , 2008, Math. Comput. Model..

[53]  P. Marchetti,et al.  Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents. , 2009, Anticancer research.

[54]  C A Condat,et al.  Cancer growth: predictions of a realistic model. , 2008, Physical review. E, Statistical, nonlinear, and soft matter physics.

[55]  R. Jenkins,et al.  Genetics of adult glioma. , 2012, Cancer genetics.

[56]  Kristin R. Swanson,et al.  The Evolution of Mathematical Modeling of Glioma Proliferation and Invasion , 2007, Journal of neuropathology and experimental neurology.

[57]  S. Willaime-Morawek,et al.  A-Disintegrin and Metalloprotease (ADAM) 10 and 17 promote self-renewal of brain tumor sphere forming cells. , 2012, Cancer letters.